What is Spinal Cord Stimulation?
Spinal Cord Stimulation (SCS) is an advanced neuromodulation therapy in which electrical pulses are delivered to the spinal cord via implanted electrodes, interrupting pain signals before they reach the brain. A small pulse generator, similar in size to a pacemaker, is implanted under the skin and connected to thin leads placed in the epidural space of the spinal column.
SCS works by replacing the sensation of pain with a mild tingling (paresthesia) or no sensation at all, depending on the stimulation type used. This technology has evolved significantly in recent years, offering patients multiple stimulation paradigms tailored to their specific pain patterns.
Conditions Treated
Spinal Cord Stimulation is indicated for a range of chronic and intractable pain conditions that have not responded adequately to conservative treatments:
- Failed Back Surgery Syndrome (FBSS) — Persistent pain following one or more spinal surgeries
- Complex Regional Pain Syndrome (CRPS) — Severe, chronic pain usually affecting a limb
- Chronic neuropathic pain — Pain caused by nerve damage
- Arachnoiditis — Inflammation of the arachnoid membrane surrounding spinal nerves
- Peripheral neuropathy — Damage to peripheral nerves causing pain and numbness
- Diabetic neuropathy — Nerve damage from diabetes
- Post-amputation pain — Phantom limb pain and residual limb pain
- Visceral abdominal and pelvic pain — Chronic organ-related pain
- Refractory angina pectoris — Chest pain not responsive to standard cardiac treatments
- Peripheral vascular disease pain — Pain from reduced blood flow to extremities
SCS Technology Types
Modern spinal cord stimulation encompasses several distinct stimulation paradigms, each offering unique therapeutic advantages:
- Traditional/Tonic SCS — Continuous low-frequency stimulation creating a mild tingling sensation (paresthesia) in the area of pain. Decades of clinical evidence supporting effectiveness.
- Burst Stimulation — Delivers electrical pulses in burst patterns mimicking natural nerve firing. Provides pain relief without the tingling sensation.
- High-Frequency (HF10) Stimulation — Operates at 10,000 Hz providing paresthesia-free pain relief at frequencies above the sensory threshold.
- Dorsal Root Ganglion (DRG) Stimulation — Targeted stimulation ideal for focal and localized pain. Particularly effective for CRPS and post-surgical pain in discrete regions.
SCS Device Types
There are three main types of SCS devices available at NuRaX, each suited to different patient needs:
- Conventional IPG (Internal Pulse Generator) — A non-rechargeable device with a battery life of 2–5 years. Simple to use with no recharging required. Ideal for patients with lower stimulation needs.
- Rechargeable IPG — A rechargeable device with a battery life of up to 10–25 years. Patients recharge the device externally for 1–2 hours per week. Best for patients requiring higher stimulation levels.
- Radio-Frequency (RF) System — An external power source delivers energy wirelessly to an implanted receiver. Offers unlimited power capacity and is suitable for patients needing very high stimulation output.
The Two-Phase Treatment Approach
The SCS implantation process follows a carefully structured approach designed to ensure optimal outcomes and patient satisfaction before committing to a permanent implant.
Pre-Surgical Evaluation
Comprehensive assessment including thorough history review, physical examination, diagnostic imaging (MRI/CT), and psychological screening to confirm candidacy for SCS therapy.
Trial Stimulation (5–7 Days)
Temporary leads are placed via a minimally invasive percutaneous procedure under local anesthesia. The patient evaluates stimulation during normal daily activities. Success is measured by achieving 50% or greater pain reduction.
Permanent Implantation
Following a successful trial, the full SCS system is implanted under general anesthesia. The IPG is placed in the buttock or abdominal area and the leads are permanently secured in the epidural space.
Programming & Optimization
Post-implant programming sessions fine-tune stimulation parameters over multiple visits. The NuRaX team optimizes frequency, pulse width, and amplitude for maximum pain relief.
Recovery & Follow-Up
Most patients resume normal activities within 2–4 weeks. Regular follow-up appointments ensure sustained outcomes, with ongoing device management and parameter adjustments as needed.
Clinical Results
Spinal Cord Stimulation has a robust evidence base demonstrating significant clinical benefits for appropriate candidates:
- Significant reduction in opioid medication use
- Improved ability to perform daily activities and return to work
- Enhanced sleep quality and mental well-being
- Better overall quality of life scores
- Cost-effective compared to ongoing pain management regimens
Risks and Considerations
As with any surgical procedure, SCS implantation carries potential risks that are discussed thoroughly with each patient during the evaluation process:
- Infection at the implant site (approximately 3–5% risk)
- Lead migration requiring repositioning
- Hardware malfunction or breakage
- Uncomfortable stimulation or change in stimulation over time
- Spinal fluid leak (rare)
- Allergic reaction to implant materials (rare)
The two-phase trial approach significantly mitigates risk, as patients experience the therapy before any permanent implant is placed.
The NuRaX SCS Program
The NuRaX SCS program provides patients with access to multiple device manufacturers and stimulation types, ensuring the most appropriate technology is selected for each individual case:
- Personalized device selection based on pain pattern analysis, anatomical considerations, and patient lifestyle factors
- Expert programming and optimization by experienced neuromodulation specialists who fine-tune stimulation parameters
- Long-term follow-up and device management ensuring sustained outcomes over years of use
- Access to latest SCS technologies including HF10, burst, and DRG stimulation from multiple manufacturers
- Global patient coordination for international patients seeking advanced pain management